Abstract:The higher prevalence of attention-deficit/hyperactivity disorder (ADHD) in males raises the question of whether testosterone is implicated in ADHD risk. However, cross-sectional studies did not identify an association between ADHD and testosterone levels. Mendelian randomization (MR) studies can overcome limitations inherent to association studies, especially of reverse causation and residual confounding. In the current study, sex-combined and sex-specific two-sample MR analyses were conducted to address whether testosterone has a causal influence on ADHD risk. Sex-combined as well as sex-specific target-genetic variants for bioavailable testosterone were derived from a large genome-wide association study (GWAS) on up to 382,988 adult white European UK Biobank study participants. In our sex-specific analyses for ADHD, including data from 14,154 males and 4,945 females with ADHD (17,948 and 16,246 controls respectively), no association between bioavailable testosterone and ADHD risk was found, neither in males (inverse-variance weighted (IVW): beta = 0.09, 95%-CI [-0.10, 0.27]) nor in females (IVW: beta=-0.01, 95%-CI [-0.20, 0.19]). However, in the sex-combined analysis, including 38,691 cases and 186,843 controls, genetically predicted bioavailable testosterone was associated with ADHD risk (IVW: beta = 0.24, 95%-CI [0.09, 0.39]). The inclusion of birth weight and/or SHBG as additional variables in multivariable MR analyses did not alter this result. However, when correcting for potential BMI-driven pleiotropy by a multivariable MR study, all effect estimates for testosterone showed non-significant results. Taken together, no robust evidence for a causal effect of bioavailable testosterone on the risk for ADHD was found.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether bioavailable testosterone has a causal impact on the risk of attention - deficit/hyperactivity disorder (ADHD). Specifically, researchers used the Mendelian Randomization (MR) method and two - sample MR analysis to evaluate the relationship between bioavailable testosterone and the risk of ADHD. The study was divided into sex - combined analysis and sex - specific analysis, aiming to explore whether there are differences in the impact of testosterone on the risk of ADHD in different genders. ### Research Background - **Epidemiology of ADHD**: ADHD is a common mental disorder in children and adolescents, and male patients are 2 - 3 times more than female patients. - **Role of Testosterone**: Animal studies have shown that the androgen testosterone can regulate neural pathways related to ADHD, such as the mesocortical and mesolimbic dopaminergic pathways. - **Limitations of Existing Studies**: Cross - sectional studies have failed to find an association between testosterone levels and ADHD, but these studies may be affected by reverse causality and residual confounding factors. ### Research Objectives - **Sex - combined Analysis**: To evaluate the overall impact of bioavailable testosterone on the risk of ADHD. - **Sex - specific Analysis**: To evaluate the impact of bioavailable testosterone on the risk of ADHD in men and women respectively. ### Research Methods - **Data Sources**: Use large - scale genome - wide association study (GWAS) data, including data from 382,988 adult white European UK Biobank participants to define genetic variations in bioavailable testosterone. - **ADHD Data**: Use GWAS data from 38,691 ADHD patients and 186,843 controls for sex - combined analysis, and data from 14,154 male and 4,945 female ADHD patients for sex - specific analysis. - **Statistical Methods**: Use methods such as inverse - variance weighted (IVW), MR - Egger, median and mode effect estimation for MR analysis, and verify the robustness of the results through various sensitivity analyses. ### Main Findings - **Sex - combined Analysis**: In the sex - combined analysis, genetically predicted bioavailable testosterone was positively associated with the risk of ADHD (IVW: β = 0.24, 95% CI [0.09, 0.39]). - **Sex - specific Analysis**: - **Men**: No significant association was found between bioavailable testosterone and the risk of ADHD (IVW: β = 0.09, 95% CI [- 0.10, 0.27]). - **Women**: Similarly, no significant association was found (IVW: β = - 0.01, 95% CI [- 0.20, 0.19]). - **Multivariable MR Analysis**: After considering potential confounding factors such as birth weight and sex - hormone - binding globulin (SHBG), all effect estimates were not significant. ### Conclusion Overall, this study did not find robust causal evidence for bioavailable testosterone on the risk of ADHD. Although a certain association was observed in the sex - combined analysis, this association was not significant in the sex - specific analysis and multivariable MR analysis. This indicates that testosterone may not be a major determinant of the risk of ADHD.

No evidence for a causal contribution of bioavailable testosterone to ADHD in sex-combined and sex-specific two-sample Mendelian randomization studies

Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes

No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study

Mendelian Randomization Analysis of the Brain, Cerebrospinal Fl Uid, and Plasma Proteome Identi Fi Es Potential Drug Targets for Attention De Fi Cit Hyperactivity Disorder

Mendelian Randomization Found No Causal Relationship Between Omega-6 Fatty Acids and Attention Deficit Hyperactivity Disorder (ADHD)

Genetic analyses implicate complex links between adult testosterone levels and health and disease

Absence of Causal Relationship Between Levels of Unsaturated Fatty Acids and ADHD: Evidence from Mendelian Randomization Study.

Exploring causal associations of antioxidants from supplements and diet with attention deficit/hyperactivity disorder in European populations: a Mendelian randomization analysis

Mediating pathways between attention deficit hyperactivity disorder and type 2 diabetes mellitus: evidence from a two-step and multivariable Mendelian randomization study

Associations between attention-deficit/hyperactivity disorder and allergic diseases: a two-sample Mendelian randomization study

Association between body mass index and sex hormones among men: Evidence from cross-sectional and Mendelian randomization studies

Association of genetically determined chronotype with circulating testosterone: a Mendelian randomization study

Plasma fatty acids and attention deficit hyperactivity disorder: a Mendelian randomization investigation

Relationships between screen time and childhood attention deficit hyperactivity disorder: a Mendelian randomization study

Two-sample Mendelian randomization analysis investigates causal associations between gut microbiota and attention deficit hyperactivity disorder

Celiac disease and attention-deficit/hyperactivity disorder: a bidirectional Mendelian randomization analysis

Investigating the shared genetic architecture between attention-deficit/hyperactivity disorder and risk taking behavior: A large-scale genomewide cross-trait analysis

Commentary on "Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction"

Meta-analysis of Genome wide Association Studies on Childhood ADHD Symptoms and Diagnosis Reveals 17 Novel Loci and 22 Potential Effector Genes

Association Between Plasma Proteome and Childhood Neurodevelopmental Disorders: A Two-Sample Mendelian Randomization Analysis

Genetically predicted testosterone and cancers risk in men: a two-sample Mendelian randomization study